Medtronic Jewel AF-Only Indication Outcomes Study Recommended By Panel
This article was originally published in The Gray Sheet
Executive Summary
A postmarket surveillance study of Medtronic's Jewel AF (model 7250) implantable cardioverter defibrillator for atrial fibrillation would address concerns about possible complications including death and stroke rate, FDA's Circulatory System Devices Advisory Panel recommended Dec. 5 in Gaithersburg, Maryland.